LexDanaLexDanabeta
Inventor

Zhaobing XU

Inventor
CN

Overview

4→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
C07KPeptides8%
PatentTitleYear
12,570,653Pyrimidine ring compound202611,655,248Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor202311,453,667Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor202211,358,950SMAC mimetics used as IAP inhibitors and use thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to MEDSHINE DISCOVERY INC (3)· patent assignee history
2022Patents assigned to CHIA TAI TIANGQING PHARMACEUTICAL GROUP CO LTD (1)· patent assignee history
2022Patents assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (1)· patent assignee history
2022–2026Based in CN· patent location history
2026Patents assigned to ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEDSHINE DISCOVERY INC32022–2026
CHIA TAI TIANGQING PHARMACEUTICAL GROUP CO LTD12022
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD12022
ZHEJIANG YANGLI PHARMACEUTICAL TECH CO LTD12026
Locations
LocationPatentsSpan
CN42022–2026